“…Our approach involved the use of a bridged diazatricyclic platform (rings ABC) containing the appropriate functionality, at C‐3 and the C‐9 substituent, for the subsequent assembly of the peripheral macrocyclic D and E rings (Scheme ). In this context, using a phenylglycinol‐derived oxazolopiperidone lactam as the starting enantiomeric scaffold, we have developed a flexible route for the generation of the aforementioned key diazatricyclic intermediates . We have also developed a straightforward two‐step sequence to build the 11‐membered E ring, in which the skipped ( Z , Z )‐octadienoate chain on C‐3, needed for the final macrolactamization, is incorporated with acceptable stereoselectivity by using a C 8 nonstabilized ylide …”